CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS von Richards, Guy, Levy, Howard, Laterre, Pierre-Francois, Feldman, Charles, Woodward, Brad, Bates, Becky M., Qualy, Rebecca L.

Volltext

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis von Barie, Philip S., Williams, Mark D., McCollam, Jill Shwed, Bates, Becky M., Qualy, Rebecca L., Lowry, Stephen F., Fry, Donald E.

Volltext

Drotrecogin Alfa (Activated) Treatment of Older Patients with Severe Sepsis von Ely, E. Wesley, Angus, Derek C., Williams, Mark D., Bates, Becky, Qualy, Rebecca, Bernard, Gordon R.

Volltext

Safety, Pharmacokinetics, and Pharmacodynamics of Drotrecogin Alfa (Activated) in Children With Severe Sepsis von Barton, Phil, Kalil, Andre C, Nadel, Simon, Goldstein, Brahm, Okhuysen-Cawley, Regina, Brilli, Richard J, Takano, Jeanne S, Martin, Lynn D, Quint, Peter, Yeh, Timothy S, Dalton, Heidi J, Gessouron, Morris R, Brown, Kellie E, Betts, Helen, Levin, Michael, Macias, William L, Small, David S, Wyss, Virginia L, Bates, Becky M, Utterback, Barbara G, Giroir, Brett P

Volltext

The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results von Dhainaut, Jean-François, Laterre, Pierre-François, LaRosa, Steven P, Levy, Howard, Garber, Gary E, Heiselman, Darell, Kinasewitz, Gary T, Light, R Bruce, Morris, Peter, Schein, Roland, Sollet, Jean-Pierre, Bates, Becky M, Utterback, Barbara G, Maki, Dennis

Volltext

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study von Laterre, Pierre-Francois, Garber, Gary, Levy, Howard, Wunderink, Richard, Kinasewitz, Gary T., Sollet, Jean-Pierre, Maki, Dennis G., Bates, Becky, Yan, Sau Chi Betty, Dhainaut, Jean-Francois

Volltext

High genetic diversity and lack of pronounced population structure in five species of sympatric Pacific eels von Gubili, Chrysoula, Schabetsberger, Robert, Poellabauer, Christine, Bates, Becky, Wagstaff, Rosa M., Woodward, Lewis M., Sichrowsky, Ursula, Scheck, Alexander, Boseto, David T., Feunteun, Eric, Acou, Anthony, Jehle, Robert

Volltext

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study von Laterre, Pierre-Francois, Garber, Gary, Levy, Howard, Wunderink, Richard, Kinasewitz, Gary T, Sollet, Jean-Pierre, Maki, Dennis G, Bates, Becky, Yan, Sau Chi Betty, Dhainaut, Jean-Francois

Volltext

Safety of Drotrecogin Alfa (Activated) in Surgical Patients with Severe Sepsis von Fry, Donald E., Beilman, Gregory, Johnson, Steven, Williams, Dr, Rodman, George, Booth, Frank V., Bates, Becky M., McCollam, Jill Shwed, Lowry, Stephen F.

Volltext

Static and Dynamic Assessment of Biomarkers in Surgical Patients with Severe Sepsis von Lowry, Stephen F., Awad, Samir, Ford, Henri, Cheadle, William, Williams, Mark D., Qualy, Rebecca L., McCollam, Jill Shwed, Bates, Becky M., Fry, Donald E.

Volltext

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial von Wheeler, Arthur, Steingrub, Jay, Schmidt, Gregory A, Sanchez, Philip, Jacobi, Judith, Linde-Zwirble, Walter, Bates, Becky, Qualy, Rebecca L, Woodward, Brad, Zeckel, Michael

Volltext

CURB-65 SCORE AS A MEASURE OF DISEASE SEVERITY IN SEVERE SEPSIS: 203-T von Levy, Howard, Qualy, Rebecca L, Bates, Becky

Volltext

CURB-65 PNEUMONIA SEVERITY INDEX AND APACHE II SCORES TO ASSESS MORTALITY RISK IN COMMUNITY-ACQUIRED PNEUMONIA PATIENTS FROM PROWESS von Richards, Guy, Levy, Howard, Laterre, Pierre-Francois, Feldman, Charles, Bates, Becky M., Qualy, Rebecca L.

Volltext

Application of a population-based severity scoring system to individual patients results in frequent misclassification von Booth, Frank V, Short, Mary, Shorr, Andrew F, Arkins, Nancy, Bates, Becky, Qualy, Rebecca L, Levy, Howard

Volltext

RESOURCE USE VARIATION AMONG SEVERE SEPSIS PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN THE XEUS STUDY: 255 von Linde-Zwirble, Walter, Ernst, Frank R, Bates, Becky, Lilly, Eli

Volltext

Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated) von Levy, Howard, Laterre, Pierre-Francois, Bates, Becky, Qualy, Rebecca L

Volltext

IMPROVED OUTCOMES IN CLOSED VERSUS OPEN MEDICAL ICUS AMONG SEVERE SEPSIS PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED): 519 von Steingrub, Jay, Cheatham, Michael, Safcsak, Karen, Linde-Zwirble, Walter, Bates, Becky, Ernst, Frank R, Effron, Mark B

Volltext

Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni von Wunderink, Richard G., Yende, Sachin, Laterre, Pierre-Francois, Joyce, David E., Bates, Becky, Levy, Howard

Volltext

Drotrecogin alfa (activated) treatment of older patients with severe sepsis. Commentary von ELY, E. Wesley, ANGUS, Derek C, WILLIAMS, Mark D, BATES, Becky, QUALY, Rebecca, BERNARD, Gordon R, HIGH, Kevin P

Volltext

CURB-65, pneumonia severity index and apache ii 25 scores to assess mortality risk in community-acquired pneumonia von Richards, Guy, Levy, Howard, Laterre, Pierre-Francois, Feldman, Charles, Bates, Becky, Qualy, Rebecca L

Volltext